November / December 2022
Features
Anti-VEGF for RVO: A look at real-world results
They don’t necessarily measure up to what clinical trials show, pointing to a need for more durable therapies.
Sickle cell retinopathy: An update on management
Laser photocoagulation is the gold standard, but adjunct anti-VEGF and current and emerging systemic therapies may help improve retinopathy.
Lessons from MEAD: The potential for reversing DR
The dexamethasone implant has shown efficacy in diabetic macular edema, but more recent evidence shows a signal for reversing diabetic retinopathy.
How AI may impact retinal practice
Artificial intelligence has shown potential for helping us to manage the multitudes with geographic atrophy and diabetes.
Departments
Clinical Trial Closeup
Axitinib implant shows early potential
Interim results from Phase I trial of OTX-TKI, a bioresorbable hydrogel platform using a tyrosine kinase inhibitor.
Conference Review
AAO highlights: ILM peel in DR and more
Standout Retina Subspecialty Day 2022 talks include real-world faricimab and high-dose aflibercept results, and Protocol T outcomes.
Editor's Page
News
North of the Border
Top 10 OCT terms for vitreoretinal surgery
A review of must-know optical coherence tomography nomenclature for the vitreoretinal surgical practice.
Retina Rounds
Can we spare the OR?
A case and discussion of macular hole management with medical therapy.
Social Media Specialist
Climate change and social media
Exploring the axis of access: Pollution, health outcomes and your social media account.
Surgical Pearl Video
Handling a GORE-TEX-sutured IOL
A review of key steps that will avoid suture twisting and lens tilt.
Current Issue
Continuing Medical Education
Additional Publications
Tuesday, October 8, 2024 | Learn More About Stargardt Disease
Location: Webinar
Time: 7:00 PM ET
Time: 7:00 PM ET
Speaker: Lejla Vajzovic, MD, FASRS
Sponsored by Alkeus Pharmaceuticals, Inc.
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
